“Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology and biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.
In 2015, the reagents segment is expected to account for the largest share of the transfection reagents and equipment market, by product; the biochemical method segment is expected to account for the largest share of the global transfection reagents and equipment market, by method; while the biomedical research segment is expected to account for the largest share of the transfection reagents and equipment market, by application.
In 2015, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and rest of the world (RoW). In future, the transfection reagents and equipment market is expected to witness the highest growth rate in the Asia-Pacific region, with emphasis on India, China, and Japan. High growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidences, and favorable regulatory framework.
The global transfection reagents and equipment market witnesses’ low competitive intensity as Thermo Fisher Scientific, Inc. (U.S.) occupies majority of the market share. However, several other players and many small firms with similar product offerings are adopting various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the transfection reagents and equipment market. The report analyzes the transfection reagents and equipment market, by product, method, and application
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the transfection reagents and equipment market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transfection methods across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the transfection technologies market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transfection reagents and equipment market
”
“TABLE OF CONTENTS
1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH METHODOLOGY STEPS 23
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 24
2.2.1 SECONDARY RESEARCH 24
2.2.1.1 Key data from secondary sources 24
2.2.2 PRIMARY RESEARCH 25
2.2.2.1 Key industry insights 26
2.2.2.2 Key data from primary sources 27
2.2.2.3 Key insights from primary sources 28
2.3 MARKET SIZE ESTIMATION METHODOLOGY 28
2.4 MARKET FORECAST METHODOLOGY 30
2.5 MARKET DATA VALIDATION AND TRIANGULATION 31
2.6 ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
3.1 INTRODUCTION 32
3.2 CURRENT SCENARIO 34
3.3 FUTURE OUTLOOK 35
3.4 CONCLUSION 37
4 PREMIUM INSIGHTS 38
4.1 GLOBAL TRANSFECTION TECHNOLOGIES MARKET 38
4.2 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION AND REGION 39
4.3 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2015 VS. 2020) 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET SEGMENTATION 42
5.3 MARKET DYNAMICS 43
5.3.1 DRIVERS 44
5.3.1.1 Growing Research Activities In Cell Science 44
5.3.1.2 Technological Advancements In Transfection Instruments And Reagents 45
5.3.1.3 Rising Incidence of Cancer Worldwide 45
5.3.1.4 Global Alliances Among Leading Research Institutes to Trigger Drug Discovery 45
5.3.2 RESTRAINTS 47
5.3.2.1 High Reliability on Grants Might Restrict Growth 47
5.3.2.2 Selective Effectiveness of Transfection Reagents 47
5.3.3 OPPORTUNITIES 48
5.3.3.1 Large-Scale Transfections likely to propel Transfection Equipment market 48
5.3.3.2 Rising Demand for Protein Therapeutics 48
5.3.3.3 Asian Market Presents High-Growth Opportunities 48
5.3.4 CHALLENGES 50
5.3.4.1 Transfection in hard-to-transfect cells 50
6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 REAGENTS 53
6.3 EQUIPMENT/INSTRUMENTS 54
7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD 55
7.1 INTRODUCTION 56
7.2 BIOCHEMICAL METHODS 57
7.2.1 CALCIUM PHOSPHATE 58
7.2.1.1 Advantages 58
7.2.1.2 Disadvantages 59
7.2.2 LIPOFECTION 59
7.2.2.1 Advantages 60
7.2.2.2 Disadvantages 60
7.2.3 DEAE-DEXTRAN 61
7.2.3.1 Advantages 61
7.2.3.2 Disadvantages 61
7.2.4 DENDRIMERS 62
7.2.4.1 Advantages 62
7.2.4.2 Disadvantages 62
7.3 PHYSICAL 63
7.3.1 INTRODUCTION 63
7.3.2 ELECTROPORATION 64
7.3.2.1 Advantages 64
7.3.2.2 Disadvantages 64
7.3.3 NUCLEOFECTION 65
7.3.3.1 Advantages 65
7.3.3.2 Disadvantages 65
7.3.4 OTHER METHODS 66
7.3.4.1 Sonoporation 66
7.3.4.2 Gene Gun 67
7.3.4.2.1 Advantages 67
7.3.4.2.2 Disadvantages 67
7.3.4.3 Magnetofection 67
7.3.4.3.1 Advantages 67
7.3.4.3.2 Disadvantages 68
7.3.4.4 Optoinjection 68
7.3.4.4.1 Advantages 68
7.3.4.4.2 Disadvantages 68
7.4 VIRAL METHODS 69
7.4.1 INTRODUCTION 69
7.4.2 ADVANTAGES 69
7.4.3 LIMITATIONS 69
8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION 71
8.1 INTRODUCTION 72
8.2 BIOMEDICAL RESEARCH 74
8.2.1 GENE EXPRESSION STUDIES 75
8.2.2 CANCER RESEARCH 76
8.2.3 TRANSGENIC MODELS 77
8.3 PROTEIN PRODUCTION 78
8.4 THERAPEUTIC DELIVERY 79
9 GLOBAL TRANSFECTION TECHNOLOGIES MARKET, BY REGION 81
9.1 INTRODUCTION 82
9.2 NORTH AMERICA 84
9.2.1 U.S. 89
9.2.1.1 Increase in Bio-Based Drug Research 89
9.2.1.2 Growing Demand for Protein-Based Therapeutics Triggers the Growth of U.S. Market 90
9.2.1.3 Growing Funding for Biotechnology and for Development of Protein Based Biologics 90
9.2.2 CANADA 93
9.2.2.1 Government Support for Development of Protein Drugs is Expected to Drive the Market for Transfection Technologies 93
9.2.2.2 Increasing Investments by the Canadian Government on Regenerative Medicine to Spur Market Growth 93
9.3 EUROPE 97
9.3.1 GERMANY 102
9.3.1.1 Advances in the Biotechnological & Research Sectors 102
9.3.1.2 Collaboration Among the Bio-Pharmaceutical and Biotechnology Companies for Development of New Vaccines is Likely the Spur the Market Growth 102
9.3.2 U.K. 106
9.3.2.1 Strong Biotechnology Industry 106
9.3.2.2 Increase in R&D Investments 106
9.3.3 FRANCE 109
9.3.3.1 Strong Biotechnology Industry in France 109
9.3.4 REST OF EUROPE (ROE) 113
9.3.4.1 Growing Biotechnology Industry in Italy and Spain 113
9.3.4.2 Investments and Funding for Life Sciences to Bolster the Transfection Technologies Market 113
9.4 ASIA-PACIFIC 117
9.4.1 JAPAN 122
9.4.1.1 Rise in Biomedical Research in Japan 122
9.4.2 CHINA 125
9.4.2.1 Increasing Government and Private Sector Investments in China’s Life Sciences Market 125
9.4.3 INDIA 129
9.4.3.1 Booming Pharmaceutical Industry and Funding for Biotechnology 129
9.4.3.2 Development of Bio-Clusters in India 129
9.4.4 PACIFIC COUNTRIES 133
9.4.4.1 Favourable Regulatory Changes to Increase the Market in New Zealand and Australia 133
9.4.4.2 Federal Collaborations in Australia 133
9.4.5 REST OF ASIA-PACIFIC 136
9.4.5.1 Rising Pharmaceutical and Biotechnology R&D Activities in Korea 136
9.4.5.2 Government Support for Strong Academic and Commercial R&D Activities in Taiwan 137
9.5 REST OF THE WORD (ROW) 140
9.5.1 LATIN AMERICA 140
9.5.1.1 Increasing Investment in Brazil and Mexico 140
9.5.2 MIDDLE EAST AND AFRICA 141
9.5.2.1 Increasing Focus of Major Pharmaceutical, Biopharmaceutical and Biotechnology Firms in Saudi Arabia and the United Arab Emirates (UAE) and African Regions 141
10 COMPETITIVE LANDSCAPE 145
10.1 OVERVIEW 145
10.2 MARKET SHARE ANALYSIS, TRANSFECTION TECHNOLOGIES MARKET (2014) 146
10.3 COMPETITIVE SITUATION AND TRENDS 148
10.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & STRATEGIC ALLIANCES 149
10.5 NEW PRODUCT LAUNCHES 152
10.6 EXPANSIONS 154
10.7 ACQUISITIONS 156
10.8 OTHERS 157
11 COMPANY PROFILES 159
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 159
11.2 THERMO FISHER SCIENTIFIC, INC. (LIFE TECHNOLOGIES) 160
11.3 PROMEGA CORPORATION 163
11.4 QIAGEN N.V. 166
11.5 POLYPLUS TRANSFECTION SA 169
11.6 ROCHE 172
11.7 BIO–RAD LABORATORIES INC. 174
11.8 LONZA GROUP 176
11.9 SIGMA- ALDRICH CORPORATION 179
11.10 MIRUS BIO LLC. 182
11.11 MAXCYTE, INC. 184
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 185
12.1 DISCUSSION GUIDE 185
12.2 COMPANY DEVELOPMENTS (2012-2015) 190
12.2.1 THERMO FISHER SCIENTIFIC, INC. 190
12.2.2 PROMEGA CORPORATION 191
12.2.3 QIAGEN N.V. 191
12.2.4 SIGMA-ALDRICH CORPORATION 192
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 193
12.4 AVAILABLE CUSTOMIZATIONS 193
12.5 RELATED REPORTS 194
“
“LIST OF TABLES
TABLE 1 INCREASING RESEARCH ACTIVITIES IN CELL SCIENCE PROPELLING GROWTH OF THE GLOBAL TRANSFECTION TECHNOLOGIES MARKET 46
TABLE 2 HIGH RELIABILITY ON RESEARCH GRANTS AND LACK OF EFFICIENCY OF TRANSFECTION REAGENTS RESTRICTING THE GROWTH OF THE GLOBAL TRANSFECTION TECHNOLOGIES MARKET 47
TABLE 3 LARGE SCALE TRANSFECTION AND RISING DEMAND OF PROTEIN THERAPEUTICS INFLUENCE THE GROWTH OF THE TRANSFECTION TECHNOLOGIES MARKET 49
TABLE 4 TRANSFECTION IN HARD-TO-TRANSFECT CELL POSE AS A CHALLENGE IN THE GROWTH OF THE TRANSFECTION TECHNOLOGIES MARKET 50
TABLE 5 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 52
TABLE 6 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR REAGENTS,
BY REGION, 2013–2020 ($MILLION) 53
TABLE 7 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR EQUIPMENT,
BY REGION, 2013–2020 ($MILLION) 54
TABLE 8 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013–2020 ($MILLION) 57
TABLE 9 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 57
TABLE 10 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD,
BY REGION, 2013-2020 ($MILLION) 58
TABLE 11 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CALCIUM PHOSPHATE METHOD, BY REGION, 2013-2020 ($MILLION) 59
TABLE 12 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR LIPOFECTION METHOD,
BY REGION, 2013-2020 ($MILLION) 60
TABLE 13 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR DEAE-DEXTRAN METHOD,
BY REGION, 2013-2020 ($MILLION) 61
TABLE 14 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR DENDRIMER METHOD,
BY REGION, 2013-2020 ($MILLION) 62
TABLE 15 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 63
TABLE 16 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY REGION, 2013-2020 ($MILLION) 64
TABLE 17 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR ELECTROPORATION,
BY REGION, 2013-2020 ($MILLION) 65
TABLE 18 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR NUCLEOFECTION,
BY REGION, 2013-2020 ($MILLION) 66
TABLE 19 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR OTHER PHYSICAL METHODS, BY REGION, 2013-2020 ($MILLION) 68
TABLE 20 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR VIRAL METHODS,
BY REGION, 2013-2020 ($MILLION) 70
TABLE 21 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 73
TABLE 22 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH,
BY TYPE, 2013-2020 ($MILLION) 74
TABLE 23 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH,
BY REGION, 2013-2020 ($MILLION) 75
TABLE 24 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR GENE EXPRESSION STUDIES, BY REGION, 2013-2020 ($MILLION) 75
TABLE 25 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CANCER RESEARCH,
BY REGION, 2013-2020 ($MILLION) 76
TABLE 26 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR TRANSGENIC MODELS,
BY REGION, 2013-2020 ($MILLION) 77
TABLE 27 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PROTEIN PRODUCTION,
BY REGION, 2013-2020 ($MILLION) 78
TABLE 28 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR THERAPEUTIC DELIVERY,
BY REGION, 2013-2020 ($MILLION) 80
TABLE 29 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 83
TABLE 30 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY COUNTRY, 2013–2020 ($MILLION) 86
TABLE 31 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2013-2020($MILLION) 86
TABLE 32 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY METHOD, 2013-2020 ($MILLION) 87
TABLE 33 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 87
TABLE 34 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 88
TABLE 35 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY APPLICATION, 2013-2020 ($MILLION) 88
TABLE 36 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 89
TABLE 37 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 90
TABLE 38 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 91
TABLE 39 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 91
TABLE 40 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 92
TABLE 41 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 92
TABLE 42 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 93
TABLE 43 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 94
TABLE 44 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 94
TABLE 45 CANADA : TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 95
TABLE 46 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 95
TABLE 47 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 96
TABLE 48 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 96
TABLE 49 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 97
TABLE 50 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 99
TABLE 51 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 99
TABLE 52 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 100
TABLE 53 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 100
TABLE 54 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 101
TABLE 55 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 101
TABLE 56 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 103
TABLE 57 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 103
TABLE 58 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 104
TABLE 59 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 104
TABLE 60 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 105
TABLE 61 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 105
TABLE 62 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 106
TABLE 63 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 107
TABLE 64 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD,
BY TYPE 2013-2020 ($MILLION) 107
TABLE 65 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD,
BY TYPE 2013-2020 ($MILLION) 108
TABLE 66 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 108
TABLE 67 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 109
TABLE 68 FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 110
TABLE 69 FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013–2020 ($MILLION) 110
TABLE 70 FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013–2020 ($MILLION) 111
TABLE 71 FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013–2020 ($MILLION) 111
TABLE 72 FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 112
TABLE 73 FRANCE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 112
TABLE 74 ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 114
TABLE 75 ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 114
TABLE 76 ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013–2020 ($MILLION) 115
TABLE 77 ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 115
TABLE 78 ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 116
TABLE 79 ROE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 116
TABLE 80 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2013–2020 ($MILLION) 117
TABLE 81 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 119
TABLE 82 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 119
TABLE 83 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 120
TABLE 84 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 120
TABLE 85 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 121
TABLE 86 APAC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 121
TABLE 87 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 122
TABLE 88 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 123
TABLE 89 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 123
TABLE 90 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 124
TABLE 91 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 124
TABLE 92 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 125
TABLE 93 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 126
TABLE 94 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013–2020 ($MILLION) 127
TABLE 95 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 127
TABLE 96 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 128
TABLE 97 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 128
TABLE 98 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 129
TABLE 99 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013-2020 ($MILLION) 130
TABLE 100 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2013-2020 ($MILLION) 130
TABLE 101 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 131
TABLE 102 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY TYPE, 2013-2020 ($MILLION) 131
TABLE 103 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 132
TABLE 104 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 132
TABLE 105 PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2013-2020 ($MILLION) 133
TABLE 106 PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY METHOD, 2013-2020 ($MILLION) 134
TABLE 107 PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 134
TABLE 108 PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 135
TABLE 109 PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY APPLICATION, 2013-2020 ($MILLION) 135
TABLE 110 PACIFIC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH , BY TYPE, 2013-2020 ($MILLION) 136
TABLE 111 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2013-2020 ($MILLION) 137
TABLE 112 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY METHOD, 2013–2020 ($MILLION) 137
TABLE 113 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 138
TABLE 114 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2013-2020 ($MILLION) 138
TABLE 115 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY APPLICATION, 2013-2020 ($MILLION) 139
TABLE 116 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013-2020 ($MILLION) 139
TABLE 117 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2013–2020 ($MILLION) 141
TABLE 118 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHODS,
2013–2020 ($MILLION) 142
TABLE 119 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2013–2020 ($MILLION) 142
TABLE 120 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY TYPE, 2013–2020 ($MILLION) 143
TABLE 121 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2013–2020 ($MILLION) 143
TABLE 122 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2013–2020 ($MILLION) 144
TABLE 123 AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012–2015 151
TABLE 124 NEW PRODUCT LAUNCHES 2012–2015 153
TABLE 125 EXPANSIONS 2012–2015 155
TABLE 126 ACQUISITIONS 2012–2015 157
TABLE 127 OTHER STRATEGIES 2012–2015 158
“
“LIST OF FIGURES
FIGURE 1 GLOBAL TRANSFECTION TECHNOLOGIES MARKET: RESEARCH METHODOLOGY STEPS 23
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 26
FIGURE 3 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 27
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 29
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 29
FIGURE 6 RESEARCH DESIGN 30
FIGURE 7 DATA TRIANGULATION METHODOLOGY 31
FIGURE 8 VIRAL TRANSFECTION METHOD MARKET TO WITNESS THE HIGHEST CAGR FROM 2015 TO 2020 33
FIGURE 9 REAGENTS COMMAND THE LARGEST MARKET SHARE IN 2015 35
FIGURE 10 THE BIOMEDICAL RESEARCH APPLICATION SEGMENT IS EXPECTED TO CONTINUE TO DOMINATE THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 36
FIGURE 11 ASIA IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 37
FIGURE 12 INCREASED CELL BASED RESEARCH ACTIVITIES TO DRIVE THE MARKET GROWTH 38
FIGURE 13 NORTH AMERICA DOMINATED THE TRANSFECTION TECHNOLOGIES MARKET IN 2015 39
FIGURE 14 APAC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 40
FIGURE 15 REAGENTS CONTINUE TO DOMINATE THE MARKET S 40
FIGURE 16 TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION 42
FIGURE 17 DRIVERS, RESTRAINTS, CHALLENGES & OPPORTUNITIES 43
FIGURE 18 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD 56
FIGURE 19 TRANSFECTION TECHNOLOGIES MARKET : BY APPLICATION 72
FIGURE 20 TRANSFECTION TECHNOLOGIES MARKET : BY REGION 82
FIGURE 21 NORTH AMERICA TRANSFECTION TECHNOLOGIES MARKET : U.S. COMMANDS THE LARGEST SHARE 85
FIGURE 22 EUROPE TRANSFECTION TECHNOLOGIES MARKET : GERMANY COMMANDS THE LARGEST SHARE 98
FIGURE 23 APAC TRANSFECTION TECHNOLOGIES MARKET : JAPAN COMMANDS THE LARGEST SHARE 118
FIGURE 24 COLLABORATIONS/AGREEMENTS/PARTNERSHIPS/ALLIANCES WAS THE KEY GROWTH STRATEGY FOR MARKET PLAYERS 145
FIGURE 25 GLOBAL TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2015 146
FIGURE 26 BATTLE FOR MARKET SHARE: COLLABORATIONS/AGREEMENTS/ PARTNERSHIPS/ALLIANCES WAS THE KEY STRATEGY 148
FIGURE 27 KEY PLAYERS FOCUSING ON AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012–2015 149
FIGURE 28 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCHES, 2012–2015 152
FIGURE 29 KEY PLAYERS FOCUSING ON EXPANSIONS, 2012-2015 154
FIGURE 30 KEY PLAYERS FOCUSING ON ACQUISITIONS, 2012–2015 156
FIGURE 31 KEY PLAYERS FOCUSING ON OTHER STRATEGIES, 2012–2015 157
FIGURE 32 GEOGRAPHIC REVENUE MIX OF TOP 4 MARKET PLAYERS 159
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 160
FIGURE 34 PROMEGA CORPORATION: COMPANY SNAPSHOT 163
FIGURE 35 QIAGEN N.V. : COMPANY SNAPSHOT 166
FIGURE 36 ROCHE: COMPANY SNAPSHOT 172
FIGURE 37 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 174
FIGURE 38 LONZA GROUP: COMPANY SNAPSHOT 176
FIGURE 39 SIGMA-ALDRICH CORPORATION : COMPANY SNAPSHOT 180
“
